314 related articles for article (PubMed ID: 34661640)
1. Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study.
Wadström BN; Wulff AB; Pedersen KM; Jensen GB; Nordestgaard BG
Eur Heart J; 2022 Sep; 43(34):3258-3269. PubMed ID: 34661640
[TBL] [Abstract][Full Text] [Related]
2. Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study.
Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
Diabetologia; 2023 Dec; 66(12):2238-2249. PubMed ID: 37776347
[TBL] [Abstract][Full Text] [Related]
3. Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study.
Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1144-1155. PubMed ID: 38511326
[TBL] [Abstract][Full Text] [Related]
4. Contribution of remnant cholesterol to cardiovascular risk.
Langsted A; Madsen CM; Nordestgaard BG
J Intern Med; 2020 Jul; 288(1):116-127. PubMed ID: 32181933
[TBL] [Abstract][Full Text] [Related]
5. Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality.
Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
Eur Heart J; 2023 Apr; 44(16):1432-1445. PubMed ID: 36631967
[TBL] [Abstract][Full Text] [Related]
6. Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction.
Doi T; Langsted A; Nordestgaard BG
J Am Coll Cardiol; 2022 Jun; 79(24):2383-2397. PubMed ID: 35710189
[TBL] [Abstract][Full Text] [Related]
7. Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality.
Doi T; Langsted A; Nordestgaard BG
Atherosclerosis; 2023 Aug; 379():117141. PubMed ID: 37217436
[TBL] [Abstract][Full Text] [Related]
8. Impact of hypertriglyceridaemia on cardiovascular mortality according to low-density lipoprotein cholesterol in a 15.6-million population.
Park HB; Arsanjani R; Hong SJ; Yi JJ; Yi SW
Eur J Prev Cardiol; 2024 Feb; 31(3):280-290. PubMed ID: 37850354
[TBL] [Abstract][Full Text] [Related]
9. Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population.
Varbo A; Nordestgaard BG
Ann Neurol; 2019 Apr; 85(4):550-559. PubMed ID: 30723955
[TBL] [Abstract][Full Text] [Related]
10. Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction.
Varbo A; Nordestgaard BG
Eur Heart J; 2021 Dec; 42(47):4833-4843. PubMed ID: 34023898
[TBL] [Abstract][Full Text] [Related]
11. Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study.
Christoffersen M; Frikke-Schmidt R; Schnohr P; Jensen GB; Nordestgaard BG; Tybjærg-Hansen A
BMJ; 2011 Sep; 343():d5497. PubMed ID: 21920887
[TBL] [Abstract][Full Text] [Related]
12. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.
Jørgensen AB; Frikke-Schmidt R; West AS; Grande P; Nordestgaard BG; Tybjærg-Hansen A
Eur Heart J; 2013 Jun; 34(24):1826-33. PubMed ID: 23248205
[TBL] [Abstract][Full Text] [Related]
13. VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins.
Balling M; Afzal S; Varbo A; Langsted A; Davey Smith G; Nordestgaard BG
J Am Coll Cardiol; 2020 Dec; 76(23):2725-2735. PubMed ID: 33272366
[TBL] [Abstract][Full Text] [Related]
14. Remnant Cholesterol and Myocardial Infarction in Normal Weight, Overweight, and Obese Individuals from the Copenhagen General Population Study.
Varbo A; Freiberg JJ; Nordestgaard BG
Clin Chem; 2018 Jan; 64(1):219-230. PubMed ID: 29021326
[TBL] [Abstract][Full Text] [Related]
15. Very Low-Density Lipoprotein Cholesterol May Mediate a Substantial Component of the Effect of Obesity on Myocardial Infarction Risk: The Copenhagen General Population Study.
Johansen MØ; Nielsen SF; Afzal S; Vedel-Krogh S; Davey Smith G; Nordestgaard BG
Clin Chem; 2021 Jan; 67(1):276-287. PubMed ID: 33409531
[TBL] [Abstract][Full Text] [Related]
16. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
[TBL] [Abstract][Full Text] [Related]
17. Elevated LDL Triglycerides and Atherosclerotic Risk.
Balling M; Afzal S; Davey Smith G; Varbo A; Langsted A; Kamstrup PR; Nordestgaard BG
J Am Coll Cardiol; 2023 Jan; 81(2):136-152. PubMed ID: 36631208
[TBL] [Abstract][Full Text] [Related]
18. Nonfasting triglycerides and risk of ischemic stroke in the general population.
Freiberg JJ; Tybjaerg-Hansen A; Jensen JS; Nordestgaard BG
JAMA; 2008 Nov; 300(18):2142-52. PubMed ID: 19001625
[TBL] [Abstract][Full Text] [Related]
19. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
Nordestgaard BG; Benn M; Schnohr P; Tybjaerg-Hansen A
JAMA; 2007 Jul; 298(3):299-308. PubMed ID: 17635890
[TBL] [Abstract][Full Text] [Related]
20. Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study.
Beheshti S; Madsen CM; Varbo A; Benn M; Nordestgaard BG
Circulation; 2018 Aug; 138(6):578-589. PubMed ID: 29593013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
